Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Plank

Showing results (121-130 of 139) with videos related to

Pageof 14
Sort By:
Infectious Disease Modelling|June 6, 2025
Real-time inference of the end of an outbreak: Temporally aggregated disease incidence data and under-reportingI Ogi-Gittins, J Polonsky, M Keita, et al.
Diabetes, Obesity & Metabolism|September 4, 2007
Insulin glulisine, insulin lispro and regular human insulin show comparable end-organ metabolic effects: an exploratory studyK Horvath, G Bock, W Regittnig, et al.
Diabetes, Obesity & Metabolism|August 12, 2015
Bioavailability of insulin detemir and human insulin at the level of peripheral interstitial fluid in humans, assessed by open-flow microperfusionM Bodenlenz, M Ellmerer, L Schaupp, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|June 12, 2010
Assessment of different techniques for subcutaneous glucose monitoring in Type 1 diabetic patients during 'real-life' glucose excursionsJ K Mader, H Weinhandl, G Köhler, et al.
The New Zealand Medical Journal|September 30, 2020
Estimated inequities in COVID-19 infection fatality rates by ethnicity for Aotearoa New ZealandNicholas Steyn, Rachelle N Binny, Kate Hannah, et al.
Communications Medicine|July 15, 2024
Jointly estimating epidemiological dynamics of Covid-19 from case and wastewater data in Aotearoa New ZealandLeighton M Watson, Michael J Plank, Bridget A Armstrong, et al.
Diabetes, Obesity & Metabolism|August 6, 2013
Efficacy, usability and sequence of operations of a workflow-integrated algorithm for basal-bolus insulin therapy in hospitalized type 2 diabetes patientsJ K Mader, K M Neubauer, L Schaupp, et al.
Biosensors & Bioelectronics|January 13, 2009
A novel automated discontinuous venous blood monitoring system for ex vivo glucose determination in humansR Schaller, F Feichtner, H Köhler, et al.
The Journal of Infectious Diseases|July 25, 2022
Sensitivity of Reverse Transcription Polymerase Chain Reaction Tests for Severe Acute Respiratory Syndrome Coronavirus 2 Through TimeRachelle N Binny, Patricia Priest, Nigel P French, et al.
Emerging Infectious Diseases|January 8, 2024
Key Challenges for Respiratory Virus Surveillance while Transitioning out of Acute Phase of COVID-19 PandemicOliver Eales, Michael J Plank, Benjamin J Cowling, et al.
Pageof 14

Showing results (121-130 of 139) with videos related to

Sort By:
Pageof 14
Infectious Disease Modelling|June 6, 2025
Real-time inference of the end of an outbreak: Temporally aggregated disease incidence data and under-reportingI Ogi-Gittins, J Polonsky, M Keita, et al.
Diabetes, Obesity & Metabolism|September 4, 2007
Insulin glulisine, insulin lispro and regular human insulin show comparable end-organ metabolic effects: an exploratory studyK Horvath, G Bock, W Regittnig, et al.
Diabetes, Obesity & Metabolism|August 12, 2015
Bioavailability of insulin detemir and human insulin at the level of peripheral interstitial fluid in humans, assessed by open-flow microperfusionM Bodenlenz, M Ellmerer, L Schaupp, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|June 12, 2010
Assessment of different techniques for subcutaneous glucose monitoring in Type 1 diabetic patients during 'real-life' glucose excursionsJ K Mader, H Weinhandl, G Köhler, et al.
The New Zealand Medical Journal|September 30, 2020
Estimated inequities in COVID-19 infection fatality rates by ethnicity for Aotearoa New ZealandNicholas Steyn, Rachelle N Binny, Kate Hannah, et al.
Communications Medicine|July 15, 2024
Jointly estimating epidemiological dynamics of Covid-19 from case and wastewater data in Aotearoa New ZealandLeighton M Watson, Michael J Plank, Bridget A Armstrong, et al.
Diabetes, Obesity & Metabolism|August 6, 2013
Efficacy, usability and sequence of operations of a workflow-integrated algorithm for basal-bolus insulin therapy in hospitalized type 2 diabetes patientsJ K Mader, K M Neubauer, L Schaupp, et al.
Biosensors & Bioelectronics|January 13, 2009
A novel automated discontinuous venous blood monitoring system for ex vivo glucose determination in humansR Schaller, F Feichtner, H Köhler, et al.
The Journal of Infectious Diseases|July 25, 2022
Sensitivity of Reverse Transcription Polymerase Chain Reaction Tests for Severe Acute Respiratory Syndrome Coronavirus 2 Through TimeRachelle N Binny, Patricia Priest, Nigel P French, et al.
Emerging Infectious Diseases|January 8, 2024
Key Challenges for Respiratory Virus Surveillance while Transitioning out of Acute Phase of COVID-19 PandemicOliver Eales, Michael J Plank, Benjamin J Cowling, et al.
Pageof 14